
Joshua McCann
Articles
-
Dec 2, 2024 |
jdsupra.com | Joshua McCann |Laura Pone
After almost a decade of waiting, Massachusetts has announced that it will open its licensing process for non-resident pharmacies. Yesterday, the Massachusetts Board of Registration in Pharmacy published a memo announcing that regulations related to the licensure of non-resident pharmacies will be promulgated in December 2024 and that the Board will begin accepting applications on January 1, 2025. The Board has established a grace period for applications through March 31, 2025.
-
Nov 25, 2024 |
mondaq.com | Laura Pone |Joshua McCann
After almost a decade of waiting, Massachusetts has announced that it will open its licensing process for non-resident pharmacies. Yesterday, the Massachusetts Board of Registration in Pharmacy published a memo announcing that regulations related to the licensure of non-resident pharmacies will be promulgated in December 2024 and that the Board will begin accepting applications on January 1, 2025. The Board has established a grace period for applications through March 31, 2025.
-
Dec 19, 2023 |
jdsupra.com | Eleanor Brown |Joshua McCann
The Centers for Medicare & Medicaid Services (“CMS”) continued its efforts to increase oversight of the Medicare program by updating Medicare provider enrollment regulations and policies through recent regulatory and sub-regulatory actions. These efforts, which are described in detail below, include updates to Medicare’s provider and supplier enrollment regulations at 42 C.F.R. §424, Subpart P and changes to the Form CMS-855A for the first time in twelve years.
-
Oct 16, 2023 |
mondaq.com | Joshua McCann |Erica L. Reagan
On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule further extending the ability to prescribe controlled substance via telemedicine through the end of 2024. On November 11, 2023, the Second Temporary Rule takes effect and extends the COVID-19 Public Health Emergency (PHE) telemedicine controlled substance prescribing flexibilities through December 31, 2024.
-
Oct 12, 2023 |
jdsupra.com | Joshua McCann |Erica L. Reagan
October 12, 2023 Joshua McCann, Pharm.D., Erica Reagan, Joelle Wilson Polsinelli + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: On October 6, 2023, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) issued a Second Temporary Rule, further extending the ability to prescribe controlled substances via telemedicine through the end of 2024. On November 11, 2023, the Second Temporary Rule takes...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →